These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1366624)
21. [Use of monoclonal antibodies in the immunotherapy of neoplasms]. Robak T Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121 [No Abstract] [Full Text] [Related]
22. Immunotoxins for treatment of leukemia and lymphoma. Uckun FM; Reaman GH Leuk Lymphoma; 1995 Jul; 18(3-4):195-201. PubMed ID: 8535182 [TBL] [Abstract][Full Text] [Related]
24. Immunotoxins in cancer therapy: Review and update. Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218 [TBL] [Abstract][Full Text] [Related]
25. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents. Bodey B; Bodey B; Siegel SE; Kaiser HE Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379 [TBL] [Abstract][Full Text] [Related]
26. Recombinant single-chain and disulfide-stabilized Fv immunotoxins for cancer therapy. Niv R; Segal D; Reiter Y Methods Mol Biol; 2003; 207():255-68. PubMed ID: 12412479 [No Abstract] [Full Text] [Related]
29. Generation of recombinant immunotoxins for specific targeting of tumor-related peptides presented by MHC molecules. Cohen CJ; Denkberg G; Segal D; Reiter Y Methods Mol Biol; 2003; 207():269-82. PubMed ID: 12412480 [No Abstract] [Full Text] [Related]
30. Recombinant immunotoxins for treating cancer. FitzGerald DJ; Kreitman R; Wilson W; Squires D; Pastan I Int J Med Microbiol; 2004 Apr; 293(7-8):577-82. PubMed ID: 15149034 [TBL] [Abstract][Full Text] [Related]
31. Immunotoxins against solid tumors. Pirker R J Cancer Res Clin Oncol; 1988; 114(4):385-93. PubMed ID: 3045130 [TBL] [Abstract][Full Text] [Related]
32. [Immunotargeting of tumors: state of the art and prospects in 2000]. Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287 [TBL] [Abstract][Full Text] [Related]
33. Recombinant antibody fragments and immunotoxin fusions for cancer therapy. Brinkmann U In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057 [TBL] [Abstract][Full Text] [Related]